Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Nov 8, 2019 (7 years ago)

Pareira (Brava)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: products were not manufactured under current good manufacturing practices.

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

Pareira (Brava) 1X Tincture, 50 mL bottle, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411.

Recalling firm
Washington Homeopathic Products, Inc.
Origin
WV, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0504-2020 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Washington Homeopathic Products, Inc.

All 2019 recalls
Class III · Low risk

Complete 30C/200C Homeopathic Kit

Labeling: Label Mix-up: Some bottles of Ferrum Phosphoricum 200C were incorrectly labeled as Ferrum Metallicum 200C.

Terminated Labeling / mix-up Washington Homeopathic Products, Inc. D-0618-2024
Class II · Moderate risk

Vaccinotoxinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1141-2022
Class II · Moderate risk

Tuberculinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1139-2022

Other cgmp deviation recalls from 2019

All cgmp deviation recalls
Class II · Moderate risk

Yeast Arrest

cGMP violations

Terminated cGMP deviation Wisconsin Pharmacal Company, LLC NDC 68093-0730-1 D-0781-2020